The role of antiepileptic drugs in sudden unexpected death in epilepsy. (December 2016)

• Record Type: Journal Article
• Authors: Aurlien, Dag; Gjerstad, Leif; Taubøll, Erik
• Is Part Of: Seizure. Volume 43(2016)
• Page Start: 56
• Page End: 60
• Publication Date: 2016-12
• Subjects: AED -- Choice -- SUDEP -- Risk; Epilepsy -- Periodicals; Epilepsy -- Periodicals; Seizures -- Periodicals; Épilepsie -- Périodiques; Electronic journals; Electronic journals; 616.853
• DOI: 10.1016/j.seizure.2016.11.005
• Languages: English
• ISSNs: 1059-1311

Abstract

Highlights: High frequency of generalized tonic-clonic seizures is the most important risk factor for SUDEP. AED treatment providing effective seizure protection is a cornerstone in its prevention. Inappropriate choice of AED may increase the risk. Increased risk may be due to lack of AED efficacy or a direct effect in predisposed individuals. Abstract: Sudden unexpected death in epilepsy (SUDEP) primarily affects young adults and is the leading cause of death related directly to seizures. High frequency of generalized tonic-clonic seizures is the most important risk factor, and effective seizure protection is probably the most important measure to prevent these tragic deaths. For several years a potential role of antiepileptic drugs (AEDs) has been discussed, but at present there is wide agreement that choice of AED therapy does not influence the risk. However, although it is well known that the efficacy and safety profiles of AEDs may differ significantly when used in the treatment of genetic epilepsy compared to symptomatic or cryptogenic epilepsy, this has generally been overlooked in epidemiologic studies of possible relationships between AEDs and SUDEP. Consequently important information about drug safety may have been lost. This review challenges the current view that no AED can increase the risk of SUDEP.